Qube Research & Technologies (QRT)
LABP

Qube Research & Technologies (QRT)’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LABP Stock Details LABP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,614
Closed -$348K – 2947
2021
Q1 		$348K Buy
+3,614
New +$472K 0.01% 1384

Other funds holding LABP

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LABP Position: Q2 2021 in Review

Qube Research & Technologies (QRT) sold out of Landos Biopharma, Inc. Common Stock (LABP) in Q2 2021, closing a stake of 3,614 shares — an estimated $348K sold.

Qube Research & Technologies (QRT) first reported a position in LABP in Q1 2021 and held it in 1 quarter. The position peaked at $348K in Q1 2021. 33 funds tracked by Wall St. Rank hold LABP as of Q2 2021.

  • Qube Research & Technologies (QRT) reported no remaining Landos Biopharma, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 3,614 Landos Biopharma, Inc. Common Stock shares in Q2 2021, an estimated $348K.
  • Qube Research & Technologies (QRT) first reported a position in Landos Biopharma, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Landos Biopharma, Inc. Common Stock position peaked at $348K in Q1 2021.
  • 33 funds tracked by Wall St. Rank held Landos Biopharma, Inc. Common Stock as of Q2 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2021, filed 13 Aug 2021.